Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Services
Return to: PBR Home | Contract Research & Services | Contract Services | News
Search Refinements

Contract Services News

View news from other Pharmaceutical sectors:
61-75 of 2360 results
Orexigen signs commercialization deal with Laboratorios Farmace´utico for Mysimba in Spain
Orexigen Therapeutics' wholly owned subsidiary Orexigen Therapeutics Ireland and Laboratorios Farmacéuticos Rovi, S.A. (ROVI) have executed a commercialization and distributorship agreement for Mysimba (naltrexone HCl / bupropion HCl prolonged release) in Spain.
Contract Research & Services > Contract Services > News
Profil Institute, HighTide Biopharmaceutical partner to develop new therapies for diabetes and NAFLD/NASH
Profil Institute for Clinical Research, a science-driven clinical research organization (CRO) focused exclusively on metabolic diseases, announced today a strategic master services agreement with Shenzhen HighTide Biopharmaceutical, a subsidiary of Shenzhen Hepalink Pharmaceutical.
Contract Research & Services > Contract Services > News
Almirall, Sun Pharma sign license deal to develop tildrakizumab for psoriasis in Europe
Sun Pharma, Sun Pharmaceutical Industries and its subsidiaries or associate companies, and Almirall have signed a licensing agreement on the development and commercialization of tildrakizumab for psoriasis in Europe.
Contract Research & Services > Contract Services > News
Kite Pharma announces exclusive license with NIH for anti-CD19 CAR product candidate
Kite Pharma has entered into an exclusive, worldwide license with the National Institutes of Health (NIH) for intellectual property related to a fully human anti-CD19 chimeric antigen receptor-based product candidate directed against B-cell malignancies.
Contract Research & Services > Contract Services > News
Trek Therapeutics acquires two antiviral inhibitors from Vertex Pharmaceuticals
Trek Therapeutics has acquired the worldwide development and commercialization rights to treat infectious disease with lomibuvir (VX-222), a non-nucleoside inhibitor of the HCV NS5B polymerase and merimepodib (VX-497), an inhibitor of inosine monosphosphate dehydrogenase with broad-spectrum antiviral properties from Vertex Pharmaceuticals.
Contract Research & Services > Contract Services > News
Chugai, Galderma sign license deal for nemolizumab
Chugai Pharmaceutical and Galderma Pharma have entered into a global license agreement for “nemolizumab” (CIM331) the anti-IL-31 receptor A humanized monoclonal antibody created by Chugai, which is currently under development for atopic dermatitis and pruritus in hemodialysis patients.
Contract Research & Services > Contract Services > News
Sapience Therapeutics signs license deal with Columbia University for novel cancer treatment
Sapience Therapeutics has entered into an exclusive license agreement with Columbia University to develop a first-in-class cancer treatment, which the Company refers to as ST-36.
Contract Research & Services > Contract Services > News
Stellar Biotechnologies, Neovacs establish new company in France
Stellar Biotechnologies and Neovacs announced the formation of Neostell, a simplified stock corporation headquartered in France, to carry out the business of the companies' joint venture, previously announced on May 11, 2016, to manufacture and sell conjugated therapeutic vaccines using Stellar's Keyhole Limpet Hemocyanin (KLH).
Contract Research & Services > Contract Services > News
GSK licenses intellectual property for respiratory disease target identified using Five Prime's platform
Five Prime Therapeutics announced that GSK exercised its option to take an exclusive license to the intellectual property related to a target under the respiratory diseases research collaboration between the companies, triggering a $1.5m license payment to Five Prime.
Contract Research & Services > Contract Services > News
RedHill Biopharma announces research collaboration with NIH for potential Ebola treatment
RedHill Biopharma signed a research collaboration agreement with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), intended to evaluate RedHill’s proprietary experimental therapy for the treatment of Ebola virus disease.
Contract Research & Services > Contract Services > News
Amgen, Daiichi Sankyo sign deal to commercialize biosimilars in Japan
Amgen and Daiichi Sankyo Company have signed an exclusive agreement to commercialize nine biosimilars in Japan.
Contract Research & Services > Contract Services > News
Aphios secures subcontract for nanoformulation of super hydrophobic anticancer drug
Aphios has been awarded a subcontract for the nanoformulation of a super hydrophobic anticancer drug administered through the Frederick National Laboratory for Cancer Research in Frederick, MD.
Contract Research & Services > Contract Services > News
Cantabio signs deal with PRF to advance development work on targeting DJ-1 protein small molecule pharmaceutical chaperone drug candidates
Cantabio Pharmaceuticals has signed an agreement with Purdue Research Foundation (PRF) to advance the company’s development work on targeting DJ-1 protein small molecule pharmaceutical chaperone drug candidates for the treatment of Parkinson’s Disease (PD) and other related neurodegenerative diseases.
Contract Research & Services > Contract Services > News
BioInvent forms process development and manufacturing collaboration with Alligator
BioInvent International has signed an agreement with Alligator Bioscience to provide process development and manufacturing services for Alligator’s new bispecific antibody, ADC-1015.
Contract Research & Services > Contract Services > News
TiGenix licenses ex-US rights for Cx601 stem cell treatment to Takeda
By PBR Staff Writer
TiGenix has sold to Takeda Pharmaceutical ex-US rights to its stem cell treatment Cx601 for complex perianal fistulas in patients with Crohn's disease.
Contract Research & Services > Contract Services > News
61-75 of 2360 results